Fulgent Genetics exec reports tax withholding on RSUs
Fulgent Genetics, Inc. President and COO Jian Xie reported routine tax-related share withholding tied to equity compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Fulgent Genetics, Inc. President and COO Jian Xie reported routine tax-related share withholding tied to equity compensation. On this Form 4, 4,361 shares of common stock were withheld at $16.31 per share to satisfy tax withholding obligations arising from the vesting of restricted stock units assumed in a prior merger.
After this tax-withholding disposition, Xie holds 370,952 common shares directly. In addition, a trust associated with him, The Hsieh Family Dynasty Trust, holds 220,816 shares indirectly; Xie serves on the trust’s investment committee and disclaims beneficial interest except for any pecuniary interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 4,361 | $16.31 | $71K |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.
- F2. Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.
Key Figures
Key Terms
restricted stock units financial
tax withholding obligations financial
Form 4 regulatory
Agreement and Plan of Merger regulatory
beneficial interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Fulgent Genetics (FLGT) President Jian Xie report in this Form 4?
Was the Jian Xie Form 4 for Fulgent Genetics (FLGT) an open-market sale?
What role does The Hsieh Family Dynasty Trust play in Jian Xie’s FLGT holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.